Mills-Peninsula Health Services

New digital health tool aims to help patients keep better tabs on diabetes

Posted on Jun 5, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Memorial Medical Center, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Research, Scroll Images

SAN FRANCISCO (Calif.) Type 2 diabetes is not curable, but it is controllable—but as any patient or doctor will tell you, managing diabetes comes with its own set of challenges.

Given the disease’s complexity, patients and doctors need to maximize their time together. To help improve the care of people with cardiometabolic conditions such as type 2 diabetes, hypertension, and high cholesterol, investigators in Sutter’s Center for Health Systems Research (CHSR) and collaborators at AstraZeneca Pharmaceuticals developed and piloted an online tool called CM-SHARE (cardiometabolic Sutter Health Advanced Reengineered Encounter) to help primary care providers better manage patients with diabetes and other cardiometabolic conditions during their office visits.

Read More

Shining Light on Multiple Sclerosis

Posted on May 30, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Research, Scroll Images, Transformation

SAN FRANCISCO, Calif. – Sutter researchers launch new digital health tool to improve care for people with multiple sclerosis

Multiple sclerosis (MS)—a potentially disabling immunologic disease of the central nervous system— affects more than 2.3 million people worldwide, including almost 1 million Americans. Despite new research and over a dozen treatments for MS, the specific cause remains unknown and the disease has no cure.

Read More

A New Lens to Study the Origin of Multiple Sclerosis

Posted on May 30, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Palo Alto Medical Foundation, Research, Scroll Images, Sutter East Bay Medical Foundation

SAN FRANCISCO, Calif. – A new research collaboration will allow Sutter to collect and analyze ‘big data’ in hopes of identifying new disease markers for Multiple Sclerosis (MS).

MS is a difficult disease to treat because its cause is unknown. 

“MS is challenging to manage because there are no biomarkers or blood tests to diagnose or understand the individual patient’s prognosis and his or her likely response to medications,” says Joanna Cooper, M.D., a Sutter neurologist and MS clinician-investigator. “We know that disease course and presentation of symptoms vary by gender, age, socioeconomic status, and ethnicity. But we don’t know which treatment would be optimal for which patients, and why.” Read More

Leading Neurologist Gives Insight on Stroke Care Innovation

Posted on May 2, 2019 in Affiliates, Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Research, Scroll Images, Sutter Medical Center, Sacramento, Transformation

SAN FRANCISCO – Every second counts in detecting and treating stroke, the leading cause of serious, long-term disability in the U.S. Each year, approximately 795,000 people suffer a stroke. New research at Sutter Health is helping bring faster, life-changing care to stroke patients through a clinical trial called BEST-MSU that will test the efficacy of Sutter’s Mobile Stroke Unit (MSU).

Read More

Mills-Peninsula Physician Receives International Achievement Award from American Diabetes Association

Posted on May 1, 2019 in Mills-Peninsula Health Services, People, Quality, Scroll Images, Uncategorized

BURLINGAME, Calif. – Congratulations to David Klonoff, M.D., FACP, FRCP (Edin), Fellow AIMBE, medical director of the Diabetes Research Institute at Mills-Peninsula Medical Center, on being the 2019 recipient of the Outstanding Physician Clinician in Diabetes Award from the American Diabetes Association. This is the highest international award for a diabetes clinician and Dr. Klonoff is the first diabetes physician from Northern California to ever receive this award.

“Being a physician at Mills-Peninsula Medical Center (MPMC) has allowed me to meet many amazing physicians, nurses and educators here, and to work on projects that can benefit patients from San Mateo County, the United States and the entire world,” Dr. Klonoff said. “Development of cutting-edge treatments for diabetes, such as the artificial pancreas, new insulins, software for dosing diabetes medications, cybersecurity standards for wearable diabetes devices and new methods for measuring glucose and Hemoglobin A1c, are what we do at MPMC.  I am very happy to be part of the great MPMC staff and to be recognized for my work as a diabetes clinician at MPMC.”

Dr. Klonoff has been a member of the medical staff at Mills-Peninsula Medical Center, part of Sutter Health, since 1981.

Dr. Klonoff, along with the seven additional recipients of the American Diabetes Association (ADA) 2019 National Scientific and Health Care Achievement Awards, will be honored in a special ceremony during the ADA’s 79th Scientific Sessions. More than 11,000 leading physicians, scientists and healthcare professionals from around the world are expected to convene at the Scientific Sessions, making it the world’s largest scientific meeting focused on diabetes research, prevention and care.

“This year’s National Scientific and Health Care Achievement Award recipients are distinguished global leaders in research, clinical care and academic medicine. Collectively, their incredible contributions and research discoveries have informed on important management strategies that helped us decrease the incidence of many serious complications of diabetes, address co-morbidities and improve quality of life for the millions of people living with diabetes,” said William T. Cefalu, M.D., Chief Scientific, Medical and Mission Officer of the ADA.

An endocrinologist specializing in the development and use of diabetes technology, Dr. Klonoff is the author of more than 300 publications and has been a principal investigator on more than 110 clinical trials, including the first randomized controlled multicenter trial of an outpatient artificial pancreas product. He chaired the scientific advisory board for developing the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first FDA-approved inhaled insulin, and the first three FDA-approved incretin drugs for diabetes.

Dr. Klonoff has served as a civilian medical officer for the U.S. Army’s Telemedicine & Advanced Technology Research Center (TATRC) for biosensors and physiologic monitoring, and chaired the CDC’s initiative, “Sticking with Safety,” for safe blood glucose monitoring to avoid transmitting blood-borne viruses. He also led technical and clinical guideline panels about continuous glucose monitoring for CLSI and the Endocrine Society.

In 2010, Dr. Klonoff received the FDA Director’s Special Citation Award, and in 2012, he was elected as a Fellow of the American Institute of Medical and Biological Engineering. That same year, he also received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialties Centre and Madras Diabetes Research Foundation of Chennai, India, which is the world’s largest diabetes clinic. In 2000 Dr. Klonoff founded Mills-Peninsula’s Dorothy L. and James E. Frank Diabetes Research Institute to facilitate development of new devices and drugs for people with diabetes.

Dr. Klonoff is the founding editor-in-chief of the Journal of Diabetes Science and Technology, and founder of the Diabetes Technology Meeting, the Digital Diabetes Congress, and the Hospital Diabetes Meeting. As diabetes technology has become ever more connected, Dr. Klonoff has also become involved in advancing security standards for internet-connected medical devices. He is a member of the Healthcare Sector Coordinating Council Joint Cyber Working Group for Medical Devices/Healthcare, and chaired the groups developing the world’s first consensus medical device cybersecurity standards. He is also a clinical professor of medicine at the University of California, San Francisco (UCSF). Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals.

 

Real-Time Research: Using Insights to Help Healthcare Today and Tomorrow

Posted on Apr 20, 2019 in Alta Bates Summit Medical Center, California Pacific Medical Center, Innovation, Mills-Peninsula Health Services, Research, Scroll Images, Transformation

SAN FRANCISCO – New research shows that weight loss during the first 12 weeks of a year-long behavioral lifestyle program can predict which participants will achieve weight loss after completing the program. This revelation, along with several others, were shared by Sutter Health’s Center for Health Systems Research (CHSR) during the recent annual meeting of the Health Care Systems Research Network (HCSRN) in Portland.

Read More